Literature DB >> 31748894

Stability and Biological Activity of E. coli Derived Soluble and Precipitated Bone Morphogenetic Protein-2.

Bastian Quaas1, Laura Burmeister2,3, Zhaopeng Li1, Alexandra Satalov4,5, Peter Behrens3,4, Andrea Hoffmann2,3, Ursula Rinas6,7.   

Abstract

PURPOSE: There is a plethora of studies on recombinant human bone morphogenetic protein-2 (rhBMP-2) application and delivery systems, but surprisingly few reports address the biophysical properties of the protein which are of crucial importance to develop effective delivery systems or to solve general problems related to rhBMP-2 production, purification, analysis and application.
METHODS: The solubility, stability and bioactivity of rhBMP-2 obtained by renaturation of E. coli derived inclusion bodies was assessed at different pH and in different buffer systems using (dynamic) light scattering and thermal shift assays as well as intrinsic fluorescence measurements and luciferase based bioassays.
RESULTS: rhBMP-2 is poorly soluble at physiological pH and higher. The presence of divalent anions further decreases the solubility even under acidic conditions. Thermal stability analyses revealed that rhBMP-2 precipitates are more stable compared to the soluble protein. Moreover, correctly folded rhBMP-2 is also bioactive as precipitated protein and precipitates readily dissolve under appropriate buffer conditions. Once properly formed rhBMP-2 also retains biological activity after temporary exposure to high concentrations of chaotropic denaturants. However, care should be taken to discriminate bioactive rhBMP-2 precipitates from misfolded rhBMP-2 aggregates, e.g. resolvability in MES buffer (pH 5) and a discrete peak in thermoshift experiments are mandatory for correctly folded rhBMP-2.
CONCLUSIONS: Our analysis revealed that E. coli derived rhBMP-2 precipitates are not only bioactive but are also more stable compared to the soluble dimeric molecules. Knowledge about these unusual properties will be helpful to design improved delivery systems requiring lower amounts of rhBMP-2 in clinical applications.

Entities:  

Keywords:  protein aggregation; protein solubility; protein stability; recombinant human bone morphogenetic protein-2; refolding

Year:  2019        PMID: 31748894     DOI: 10.1007/s11095-019-2705-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

1.  Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model.

Authors:  H Uludag; D D'Augusta; J Golden; J Li; G Timony; R Riedel; J M Wozney
Journal:  J Biomed Mater Res       Date:  2000-05

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 3.  The ImageJ ecosystem: An open platform for biomedical image analysis.

Authors:  Johannes Schindelin; Curtis T Rueden; Mark C Hiner; Kevin W Eliceiri
Journal:  Mol Reprod Dev       Date:  2015-07-07       Impact factor: 2.609

4.  Coating of titanium implant materials with thin polymeric films for binding the signaling protein BMP2.

Authors:  Corinna Lorenz; Andrea Hoffmann; Gerhard Gross; Henning Windhagen; Philip Dellinger; Kai Möhwald; Wibke Dempwolf; Henning Menzel
Journal:  Macromol Biosci       Date:  2010-11-15       Impact factor: 4.979

5.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation.

Authors:  T K Sampath; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Critical assessment of rhBMP-2 mediated bone induction: an in vitro and in vivo evaluation.

Authors:  Marta Kisiel; Manuela Ventura; Oommen P Oommen; Anu George; X Frank Walboomers; Jöns Hilborn; Oommen P Varghese
Journal:  J Control Release       Date:  2012-08-10       Impact factor: 9.776

7.  Nonlinear effect of GdnHCl on hydration dynamics of proteins: a 1H magnetic relaxation dispersion study.

Authors:  M Trivikram Rao; Abani K Bhuyan; K Venu; V S S Sastry
Journal:  J Phys Chem B       Date:  2009-05-14       Impact factor: 2.991

8.  Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing.

Authors:  Koichi Yano; Masatoshi Hoshino; Yoichi Ohta; Tomoya Manaka; Yoshifumi Naka; Yuuki Imai; Walter Sebald; Kunio Takaoka
Journal:  J Bone Miner Metab       Date:  2009-02-21       Impact factor: 2.626

9.  Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.

Authors:  Luis Felipe Vallejo; Ursula Rinas
Journal:  Biotechnol Bioeng       Date:  2004-03-20       Impact factor: 4.530

10.  Novel regulators of bone formation: molecular clones and activities.

Authors:  J M Wozney; V Rosen; A J Celeste; L M Mitsock; M J Whitters; R W Kriz; R M Hewick; E A Wang
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  4 in total

1.  Bone Morphogenetic Protein 2 (BMP-2) Aggregates Can be Solubilized by Albumin-Investigation of BMP-2 Aggregation by Light Scattering and Electrophoresis.

Authors:  Julius Sundermann; Holger Zagst; Judith Kuntsche; Hermann Wätzig; Heike Bunjes
Journal:  Pharmaceutics       Date:  2020-11-25       Impact factor: 6.321

2.  ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in "Physiological" Buffers and an Interfering Effect of Chitosan.

Authors:  Julius Sundermann; Steffen Sydow; Laura Burmeister; Andrea Hoffmann; Henning Menzel; Heike Bunjes
Journal:  Pharmaceutics       Date:  2021-04-19       Impact factor: 6.321

3.  The Effect of the Topmost Layer and the Type of Bone Morphogenetic Protein-2 Immobilization on the Mesenchymal Stem Cell Response.

Authors:  Magdalena Wytrwal-Sarna; Małgorzata Sekuła-Stryjewska; Agata Pomorska; Ewa Ocłoń; Katarzyna Gajos; Michal Sarna; Ewa Zuba-Surma; Andrzej Bernasik; Krzysztof Szczubiałka
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

4.  Synthesis of Human Bone Morphogenetic Protein-2 (hBMP-2) in E. coli Periplasmic Space: Its Characterization and Preclinical Testing.

Authors:  João E Oliveira; Miriam F Suzuki; Renata Damiani; Eliana R Lima; Kleicy C Amaral; Anderson M S Santos; Geraldo S Magalhães; Leonardo P Faverani; Luís A V D Pereira; Paolo Bartolini
Journal:  Cells       Date:  2021-12-14       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.